C

Cogent Biosciences

Develops small-molecule therapies for rare diseases

Associate Director - Analytical Development

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • A PhD in Chemistry, Pharmaceutical Sciences, Chemical Engineering, or a related scientific discipline with 8 or more years of relevant industry experience; alternatively, a Master's degree with 10 or more years of experience, or a Bachelor's degree with 12 or more years of experience.
  • Experience in analytical development, analytical reporting, CMC technical writing, or related pharmaceutical development functions.
  • Strong understanding of small molecule analytical development, method validation, method transfer, stability testing, specifications, and control strategies.
  • Demonstrated experience authoring, reviewing, and approving technical documents, including analytical methods, protocols, reports, and regulatory-supporting documentation.
  • Experience reviewing analytical data generated by CDMOs, CROs, and external testing laboratories.
  • Working knowledge of analytical techniques such as HPLC/UPLC, GC, dissolution, spectroscopy, mass spectrometry, wet chemistry, particle size analysis, and related pharmaceutical characterization methods.
  • Familiarity with ICH, FDA, EMA, and other global regulatory requirements related to analytical development and CMC documentation.
  • Strong scientific writing, data interpretation, problem-solving, and project management skills.
  • Excellent verbal and written communication skills, including the ability to communicate complex technical information to diverse audiences.
  • Ability to work effectively within a cross-functional matrix organization and build strong relationships with internal stakeholders and external partners.
  • Ability to manage multiple priorities in a fast-paced biotech environment.

Responsibilities

  • Lead the preparation, review, and approval of analytical reports, data summaries, protocols, specifications, methods, and other CMC technical documentation.
  • Review analytical data packages supporting release testing, stability studies, drug substance, intermediates, and drug product manufacturing activities.
  • Partner with Regulatory CMC, Quality, and external CDMOs to ensure timely delivery of analytical documentation and reports.
  • Support analytical method development, validation, qualification, transfer, and lifecycle management activities across development and commercial programs.
  • Author, review, and manage technical documents, including analytical methods, validation protocols and reports, specifications, trend reports, and regulatory submission documentation.
  • Coordinate analytical reporting activities for drug substance and drug product stability programs and ensure data are accurately documented and communicated.
  • Support preparation and review of CMC sections for regulatory submissions, responses to health authorities, and other regulatory filings.
  • Participate in analytical investigations related to deviations, out-of-specification results, out-of-trend results, and laboratory events, ensuring documentation meets quality and regulatory expectations.
  • Collaborate with external laboratories and CDMOs to ensure analytical deliverables are scientifically sound, compliant, and aligned with program timelines.
  • Drive continuous improvement initiatives focused on analytical reporting processes, data integrity, document quality, and operational efficiency.

Desired Qualifications

  • Experience supporting late-stage development or commercial programs.
  • Experience contributing to IND, NDA, MAA, or other global regulatory submissions.

About the Company

Cogent Biosciences

Develops small-molecule therapies for rare diseases

Cogent Biosciences develops small molecule therapies for rare, genetically driven diseases. Its work centers on discovering and advancing compounds that can address conditions with limited treatment options, using a research-driven approach to guide drug discovery and development through clinical trials. The lead candidate, CGT9486, is progressing in three clinical trials planned for this year, alongside ongoing work in collaboration with partners. The company differentiates itself through its focus on genetically defined diseases, its emphasis on targeted small molecules, and its strategy of advancing candidates via internal science and partnerships, supported by a strong financial position that includes a cash reserve of $242.2 million. Cogent’s goal is to bring effective therapies to patients with unmet needs by progressing its drug candidates toward potential commercialization and forming strategic collaborations to maximize development and access.

Company size
201-500
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Cogent Biosciences

See more jobs